Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thy-α1 for RIF
NCT07675980Phase 3Recruiting
- Sponsor
- Fakih IVF Fertility Center
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 3 trial of thymosin alpha 1 in Recurrent Implantation Failure (RIF), sponsored by Fakih IVF Fertility Center. Started Feb 2026; status: recruiting.
02
Drugs
thymosin alpha 1
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT07675980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07675980.